Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades
Related FOE
Sigma-Aldrich (SIAL) Clocks New 52-Week High
Credit Suisse Sees M&A Opportunities On Near Horizon For Ferro
Related ABX
Morgan Stanley: Barrick Gold Must Cut Debt Before Executing Its 'Back To The Future' Plan
Barrick Gold Rallies Off Q4 Beat To A Major Resistance Level
Barrick Gold: Will 2015 Be A Rebound Year? (Seeking Alpha)

Analysts at Deutsche Bank upgraded Ferro (NYSE: FOE) from “hold” to “buy.” The target price for Ferro is set to $8. Ferro's shares closed at $6.73 yesterday.

Analysts at BMO Capital upgraded Barrick Gold (NYSE: ABX) from “underperform” to “market perform.” The target price for Barrick Gold has been raised from $17 to $18. Barrick Gold's shares closed at $16.81 yesterday.

Analysts at Aegis Capital upgraded Cubist Pharmaceuticals (NASDAQ: CBST) from “hold” to “buy.” The target price for Cubist Pharmaceuticals is set to $70. Cubist's shares closed at $64.80 yesterday.

Analysts at Cantor Fitzgerald upgraded LinkedIn (NYSE: LNKD) from “hold” to “buy” The target price for LinkedIn has been raised from $170 to $250. LinkedIn's shares closed at $213.00 yesterday.

Latest Ratings for FOE

DateFirmActionFromTo
Feb 2015Deutsche BankMaintainsBuy
Dec 2014JP MorganMaintainsNeutral
Oct 2014Deutsche BankMaintainsBuy

View More Analyst Ratings for FOE
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (CBST + ABX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Our Experts vs. S&P 500Powered by Benzinga
Marketfy Products Return S&P 500
Morning Profit Maker 42.72% 6.69%
The Option Prophet 91.14% 6.69%
SecretCaps 26.55% 6.69%
Short-Term Trend Trading 11.89% 6.69%
View the highest rated products→